Skip to main content
Equibles
TLLTF logo

TLLTF · TILT Holdings Inc. · Metrics

Track TLLTF — free

Use TLLTF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TLLTF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2025

Substantial doubt about the company's ability to continue as a going concern.

“Management has concluded, and the report of our auditors included in our Annual Report on Form 10-K reflect, that there is substantial doubt about our ability to continue as a going concern within 12 months after the date of this filing.”
View the 10-Q filed Aug 14, 2025
Market Cap
$43,510
Shares
347.46M
Volume — Avg daily vol (3M) —

TLLTF metrics

37 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
—
Market cap
$43,510

Price action

20 metrics
Price change (1W)
—
Price change (30D)
—
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
—
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
347.46M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.0×
reciprocal yield 212,231.7%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
0.0
reciprocal yield 12,902.8%
Earnings yield
-182,427.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-08-14

Profitability

9 metrics
Gross margin
16.2%
Operating margin
-75.4%
Trailing 12 months
Net margin
-86.0%
Gross profit (TTM)
$14.96M
Operating profit (TTM)
−$69.67M
Net income (TTM)
−$79.37M
Trailing 12 months
Diluted EPS (TTM)
$-0.24
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.24
Gross profit per diluted share (TTM)
$0.04
Operating profit per diluted share (TTM)
$-0.18
EBITDA per diluted share (TTM)
$-0.14
Net income per diluted share (TTM)
$-0.20
Operating cash flow per diluted share (TTM)
$0.01
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.10

Growth

11 metrics
Revenue growth YoY
-44.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$92.34M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
-17.1%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-57.4%
Debt / equity
—
Current ratio
0.2
EBITDA (TTM)
−$53.15M
Free cash flow (TTM)
—
Quick ratio
0.2
Interest coverage
-2.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$2.90M
Total assets
$138.29M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$5.61M
Capital expenditures (TTM)
$2.93M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1761510 Visit website